Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 12, 2007, Pages 643-653

  Haider, S Imran ^a   Johnell, K ^a   Thorslund, M ^a,b   Fastbom, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Drug use; Drug drug interactions; Education; Elderly; Patient safety; Polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CELECOXIB; DEXTROPROPOXYPHENE; DICLOFENAC; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; IBUPROFEN; IPRATROPIUM BROMIDE; KETOROLAC; LEVODOPA; LEVOTHYROXINE; METOPROLOL; MOCLOBEMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOBARBITAL; QUININE; ROFECOXIB; SOTALOL; SPIRONOLACTONE; TERBUTALINE; UNINDEXED DRUG; VERAPAMIL; VITAMIN B COMPLEX; WARFARIN;

AGE DISTRIBUTION; AGED; ARTICLE; DRUG SURVEILLANCE PROGRAM; DRUG USE; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; HEALTH HAZARD; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; OUTCOMES RESEARCH; POLYPHARMACY; SEX DIFFERENCE; SOCIOECONOMICS; SWEDEN; TREND STUDY;

EID: 37249009179     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45643     Document Type: Article

References (42)

1. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol. 2000; 56: 501-509.
2. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003; 21: 153-158.
3. Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997; 53: 7-11.
4. Bureau PR. World Population Data Sheet. Available at: http://www.prb.org. Last accessed July 15. 2006
5. Chen YF, Dewey ME, Avery AJ. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther. 2001; 26: 129-140.
6. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, Glynn RJ, Ostfeld AM, Guralnik JM. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992; 47: M137-144.
7. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Menard JF, Bercoff E. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1,000 patients. J Am Geriatr Soc. 1996; 44: 944-948.
8. Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, Markides K. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci. 2006; 61: 170-175.
9. Fasthom J. Äldre och Läkemedel [Drugs and Elderly] (in Swedish). Delrapport 7 i projektet Äldre och Folkhälsa. Rapporter/ Stiftelsen Stockholms Läns Äldrecentrum. 2000.
10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults - Results of a US consensus panel of experts. Arch Intern Med. 2003; 163: 2716-2724.
11. Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE, Jr., Brock D. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health. 1993; 83:1577-1582.
12. Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000; 55: M554-559.
13. Freedman VA, Martin LG, Schoeni RF. Recent trends in disability and functioning among older adults in the United States: A systematic review. JAMA. 2002; 288: 3137-3146.
14. Furu K, Straume B, Thelle DS. Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol. 1997; 50: 341-349.
15. Fux R, Greiner D, Geldmacher M, Morike K, Gleiter CH. Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety. Int J Clin Pharmacol Ther. 2006; 44: 539-547.
16. Giron MST, Claesson C, Thorslund M, Oke T, Winblad B, Fastbom J. Drug use patterns in a very elderly population - A seven-year review. Clin Drug Invest. 1999; 17: 389-398.
17. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population. Am J Emerg Med. 1996; 14: 447-450.
18. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001; 38: 666-671.
19. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001; 35: 1004-1009.
20. Jylha M. 10-year change in the use of medical drugs among the elderly - a longitudinal-study and cohort comparison. J Clin Epidemiol. 1994; 47: 69-79.
21. Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuoplo 75+ study. Eur J Clin Pharmacol. 2006; 62: 151-158.
22. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005; 22: 69-82.
23. Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000; 38: 504-513.
24. Lahelma E, Kivela K, Roos E, Tuominen T, Dahl E, Diderichsen F, Elstad JI, Lissau I, Lundberg O, Rahkonen O, Rasmussen NK, Yngwe MA. Analysing changes of health inequalities in the Nordic welfare states. Soc Sci Med. 2002; 55: 609-625.
25. Lernfelt B, Samuelsson O, Skoog I, Landahl S. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol. 2003; 59: 637-644.
26. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002; 55: 809-817.
27. Lundberg O, Diderichsen F, Yngwe MA. Changing health inequalities in a changing society? Sweden in the mid-1980s and mid-1990s. Scand J Public Health Suppl. 2001; 55: 31-39.
28. Lundberg O, Thorslund M. Fieldwork and measurement considerations in surveys of the oldest old. Soc Indic Res. 1996; 37: 165-187.
29. Mannesse CK, Derkx FH, de Ridder MA, Man in't Veld AJ, van der Cammen TJ. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000; 29: 35-39.
30. Muratet C, Lapeyremestre M, Montastruc JL. Study on the regular use of drugs in workers over 50 years of age. Clin Drug Invest. 1995; 9: 1-7.
31. Nielsen MW, Hansen EH, Rasmussen NK. Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol. 2003; 59: 677-684.
32. Nobili A, Tettamanti M, Frattura L, Spagnoli A, Ferraro L, Marrazzo E, Ostino G, Comelli M. Drug use by the elderly in Italy. Ann Pharmacother. 1997; 31: 416-422.
33. Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Drug use during early pregnancy. The impact of maternal illness, outcome of prior pregnancies and sociodemographic factors. Eur J Clin Pharmacol. 2001; 57: 259-263.
34. Parker MG. Sweden and the United States: is the challenge of an aging society leading to a convergence of policy? J Aging Soc Policy. 2000; 12: 73-90.
35. Parker MG, Ahacic K, Thorslund M. Health changes among Swedish oldest old: Prevalence rates from 1992 and 2002 show increasing health problems. J Gerontol A Biol Sci Med Sci. 2005; 60: 1351-1355.
36. Rosholm JU, Christensen K. Relationship between drug use and self-reported health in elderly Danes. Eur J Clin Pharmacol. 1997; 53: 179-183.
37. Sjöqvist F., Drug interactions (in Swedish). In: FASS. Läkemedel i Sverige. Förteckning över humanläkemedel. Stockholm, Sweden: Läkemedelsinformation (L1NFO). 1997; 1220-1273.
38. Stuart B, Kamal-Bahl S, Briesacher B, Lee E, Doshi J, Zuckerman IH, Verovsky I, Beers MH, Erwin G, Friedley N. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother. 2003; 1: 61-74.
39. Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol. 1999; 55: 411-415.
40. van der Meer JB, van den Bos J, Mackenbach JP. Socioeconomic differences in the utilization of health services in a Dutch population: the contribution of health status. Health Policy. 1996; 37: 1-18.
41. Veehof L, Stewart RE, Haaijer-Ruskamp FM, Meyboom-de Jong B. The development of polypharmacy. A longitudinal study. Fam Pract. 2000; 17: 261-267.
42. WHO. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway. 2003.